NCT06938763View on ClinicalTrials.gov

Evaluation of the Safety, Tolerability, and Pharmacokinetics of J4 in Healthy Adults

PHASE1RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 14, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Alzheimer Disease
Interventions
DRUG

J4

dry powder capsule

DRUG

Placebo

Placebo dry powder capsule

Trial Locations (1)

110

RECRUITING

Taipei Medical University Hospital, Taipei

All Listed Sponsors
lead

Academia Sinica, Taiwan

OTHER